To have the right for equal access to timely high-quality care is a paramount in EFA’s agenda and interaction with our community of members. In 2023, a crucial year for the negotiations around medicines and the environment, EFA rolled out our access to care agenda through three important projects, such as the advocacy around the burden of atopic eczema, the launch of EFA’s AboutAsthma.org website (a patient education resource) and the revision of our own 2013 COPD Standards of Care. We also brought meaningful and sustained feedback and guidance into EU research projects in all EFA disease areas: allergy, atopic eczema, asthma, and COPD.